International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

Early Morning Symposium
Chairs: Egbert E.F. Smit (Amsterdam, Netherlands)
Aims: Organised by Novartis Pharma AG

Welcome and introduction Egbert E.F. Smit (Amsterdam, Netherlands)
How novel targeted therapies have changed patient outcomes in ALK+ NSCLC Egbert E.F. Smit (Amsterdam, Netherlands)
Molecular characterization and diagnosis of ALK+NSCLC Lukas Bubendorf (Basel, Switzerland)
The key role of pulmonologists in the NSCLC multidisciplinary team Jacques Cadranel (Paris, France)